{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-067978","form_type":"8-K","ticker":"CDXS","cik":"0001200375","company_name":"CODEXIS, INC.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.108821+00:00","generated_at":"2026-05-24T01:32:25.689615+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Codexis appoints Cynthia Collins to Board of Directors as Class II director","bullets":["Appointed effective March 28, 2025 as Class II director; term expires at 2027 annual meeting.","Board determined Collins is independent under Nasdaq rules; appointed to Compensation Committee.","Previously CEO of Editas Medicine (2019-2021); currently Executive Chair/Interim CEO of Nutcracker Therapeutics.","Receives $50k annual cash retainer plus $20k for committee; initial RSU grant of ~$200k vesting over 3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-067978","json":"https://secwatch.observer/filing/0001193125-25-067978.json","markdown":"https://secwatch.observer/filing/0001193125-25-067978.md","text":"https://secwatch.observer/filing/0001193125-25-067978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1200375/000119312525067978/0001193125-25-067978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1200375/000119312525067978/d915487d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:32:25.689615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7a9da1b20a","claim":"Cynthia Collins was appointed as Member of the Board, Class II Director at CODEXIS, INC..","evidence_excerpt":"On March 28, 2025, the Board of Directors (the “Board”) of Codexis, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Cynthia Collins as a member of the Board as a Class II director, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1200375/000119312525067978/0001193125-25-067978-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Member of the Board, Class II Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}